UroGen Pharma Ltd. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UroGen Pharma Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in UroGen Pharma Ltd. for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 6,249 | |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,042 | 0 | 6,249 | |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 29.68 | 360 | 10,685 | 6,120 | 6.5 K to 6.1 K (-5.56 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Sell | S | 29.68 | 360 | 10,685 | 6,120 | 6.5 K to 6.1 K (-5.56 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 6,480 | 5.4 K to 6.5 K (+19.16 %) |
| Feb 24 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Buy | M | 0.00 | 1,042 | 0 | 6,480 | 5.4 K to 6.5 K (+19.16 %) |
| Feb 18 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,759 | 0 | 7,037 | |
| Feb 18 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 28.04 | 612 | 17,160 | 9,812 | 10.4 K to 9.8 K (-5.87 %) |
| Feb 18 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,759 | 0 | 10,424 | 8.7 K to 10.4 K (+20.30 %) |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Off ... | Option Exercise | A | 29.41 | 15,000 | 441,150 | 15,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 29.41 | 15,000 | 441,150 | 15,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Offic ... | Option Exercise | A | 29.41 | 15,000 | 441,150 | 15,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Feb 04 2020 | URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Off ... | Option Exercise | A | 29.41 | 45,000 | 1,323,450 | 45,000 |